Lucid Diagnostics
LUCD
19 hedge funds and large institutions have $2.49M invested in Lucid Diagnostics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
0.82% less ownership
Funds ownership: 4.9% → 4.08% (-0.82%)
5% less capital invested
Capital invested by funds: $2.6M → $2.49M (-$118K)
17% less funds holding
Funds holding: 23 → 19 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LM
Luminus Management
Houston,
Texas
|
+$42K |
| 2 |
VF
Virtu Financial
New York
|
+$21.5K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
+$19.8K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.39K |
| 5 |
BlackRock
New York
|
+$856 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$181K |
| 2 |
LCS
Levin Capital Strategies
New York
|
-$50K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$24.7K |
| 4 |
Millennium Management
New York
|
-$24K |
| 5 |
ACP
Arcus Capital Partners
Atlanta,
Georgia
|
-$4.22K |
LUCD Hedge Fund Activity: Q1 2023 in Review
19 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q1 2023, worth a combined $2.49M — down 4.5% from $2.6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of LUCD and 1 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 6 added.
The largest buyer was Luminus Management, adding an estimated $42K. The largest seller was Kornitzer Capital Management, exiting entirely with an estimated $181K sold.
- 19 institutional investors held Lucid Diagnostics (LUCD) as of Q1 2023, down from 23 in Q4 2022.
- Funds reported $2.49M of Lucid Diagnostics stock for Q1 2023, down 4.5% quarter-over-quarter.
- 1 fund opened new Lucid Diagnostics positions in Q1 2023 and 5 closed out, a net change of -4 holders.
- The largest Lucid Diagnostics buyer in Q1 2023 was Luminus Management, an estimated $42K added.
- The largest Lucid Diagnostics seller in Q1 2023 was Kornitzer Capital Management, an estimated $181K sold.
Based on aggregated 13F filings for Q1 2023.